Development and Characterization of Terminalia arjuna Phospholipid Complex and Its Tablet Formulation by Qbd Approach

被引:3
|
作者
Saudagar, Waghmare Sagar [1 ]
Sidram, GiramPadamja [2 ]
Baburo, GholveSachin [1 ]
Agarwal, Gaurav Agarwal Shilpi [3 ]
Gadgeppa, Bhusnure Omprakash [1 ]
机构
[1] Channabasweshwar Pharm Coll, Dept Qual Assurance, Kava Rd, Latur 413512, Maharashtra, India
[2] Channabasweshwar Pharm Coll, Dept Pharmacol, Kava Rd, Latur 413512, Maharashtra, India
[3] Shikhar Inst Pharm, Budaun, Uttar Pradesh, India
来源
INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH | 2021年 / 11卷 / 03期
关键词
QbD approach; Terminalia arjuna extract; Cardioprotective; Terminalia arjunaphytosome complex; Tablet formulation;
D O I
10.22376/ijpbs/lpr.2021.11.3.P14-28
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Phytosomes are a newly introduced novel drug delivery system and novel botanical formulation to induce lipophilic molecular complexes to enhance absorption and bioavailability of phytoconstituents. Terminali aarjuna phospholipid complex and it's tablet formulations targeted for cardiovascular systems was prepared. Our study aims is for improving the cardioprotective activity by formulating Terminalia arjuna phospholipid complex tablet by using solvent evaporation method. and characterized by various parameters like solubility studies, particle size determination, infrared absorption (FTIR), Scanning electron microscopy (SEM), entrapment efficiency etc. as well as by applying QbD approach various general characteristics such as entrapment efficiency etc were also done. A QbD-based approach using a Box-Behnken design was done to obtain a response surface design expert software 9.0.5 to systematically study the combined influence of the formulation and process variables such as the phospholipids-drug ratio(X1, w/w), the reaction temperature(X2, degrees C), and the reaction time (X3, hrs) on a critical quality attributes (CQAs) of the product i.e., the entrapment efficiency. Using this design, the experimental trials were carried out at all 15 possible combinations. The preliminary investigation of the influence of factors revealed that all the tested variables, i.e., the phospholipids to drug ratio, the reaction temperature and the reaction time had a significant influence on the entrapment efficiency of the prepared phytosomes. The study revealed that the entrapment efficiency of Terminalia arjuna Phytosomes was found to be 83.0-97.9 %w/w.
引用
收藏
页码:14 / 28
页数:15
相关论文
共 50 条
  • [11] FORMULATION OF ORODISPERSIBLE TABLETS CONTAINING PARACETAMOL AND THEIR IN VITRO CHARACTERIZATION - A QbD APPROACH
    Muntean, Andrei Catalin
    Negoi, Oana Iuliana
    Rus, Luca Liviu
    Vonica, Andreea Loredana
    Tomuta, Ioan
    FARMACIA, 2020, 68 (03) : 436 - 446
  • [12] Fixed Dose Single Tablet Formulation with Differential Release of Amlodipine Besylate and Simvastatin and Its Pharmacokinetic Profile: QbD and Risk Assessment Approach
    Kanwal, Ummarah
    Mukhtar, Shahid
    Waheed, Muzzamil
    Mehreen, Arifa
    Abbas, Nasir
    Shamim, Rahat
    Hussain, Khalid
    Rasool, Fatima
    Hussain, Amjad
    Bukhari, Nadeem Irfan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 2193 - 2210
  • [13] Developing Alfuzosin Tablet Formulation Based on Quality by Design (QbD) Approach by Using Artificial Neural Network
    Aksu, Buket
    Mesut, Burcu
    Ozsoy, Yildiz
    LATIN AMERICAN JOURNAL OF PHARMACY, 2019, 38 (04): : 668 - 676
  • [14] QBD-based systematic development of BosentanSNEDDS: Formulation, characterization and pharmacokinetic assessment
    Panigrahi, Kahnu Charan
    Jena, Jayashree
    Jena, Goutam Kumar
    Patra, Ch Niranjan
    Rao, M. E. Bhanoji
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2018, 47 : 31 - 42
  • [15] DEVELOPMENT AND CHARACTERIZATION OF LORATADINE LIPOSOMAL GEL USING QbD APPROACH
    Toma, Ioana
    Tefas, Lucia Ruxandra
    Bogdan, Catalina
    Tomuta, Ioan
    FARMACIA, 2022, 70 (02) : 204 - 213
  • [16] Formulation Development of Doxycycline-Loaded Lipid Nanocarriers using Microfluidics by QbD Approach
    Lee, Chia Ying
    Su, Chi-Ting
    Tsai, Tsuimin
    Hsieh, Chien-Ming
    Hung, Kuan-Yu
    Huang, Jeng-Wen
    Chen, Chin -Tin
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 112 (03) : 740 - 750
  • [17] Development of anti-angiogenic erlotinib liposomal formulation for pulmonary hypertension: a QbD approach
    Sagar Dhoble
    Vandana Patravale
    Drug Delivery and Translational Research, 2019, 9 : 980 - 996
  • [18] Development of anti-angiogenic erlotinib liposomal formulation for pulmonary hypertension: a QbD approach
    Dhoble, Sagar
    Patravale, Vandana
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2019, 9 (05) : 980 - 996
  • [19] Topical arginine solid lipid nanoparticles: Development and characterization by QbD approach
    Patel, Dinal
    Patel, Mehul
    Soni, Tejal
    Suhagia, Bhanubhai
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2021, 61
  • [20] Quality by Design (QbD) approach to optimize the formulation of a bilayer combination tablet (Telmiduo®) manufactured via high shear wet granulation
    Lee, Ah Ram
    Kwon, Seok Young
    Choi, Du Hyung
    Park, Eun Seok
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 534 (1-2) : 144 - 158